The store will not work correctly when cookies are disabled.
4-hydroxy-6-(3-methoxyphenethyl)pyridazin-3(2H)-one
ID: ALA2338799
PubChem CID: 71655605
Max Phase: Preclinical
Molecular Formula: C13H14N2O3
Molecular Weight: 246.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc(CCc2cc(O)c(=O)[nH]n2)c1
Standard InChI: InChI=1S/C13H14N2O3/c1-18-11-4-2-3-9(7-11)5-6-10-8-12(16)13(17)15-14-10/h2-4,7-8H,5-6H2,1H3,(H,14,16)(H,15,17)
Standard InChI Key: RPPHASUEWQGCLO-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
21.8661 -16.8473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8661 -17.6687 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.5755 -18.0731 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2807 -17.6687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2807 -16.8473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5755 -16.4305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9920 -18.0783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.9938 -16.4367 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1530 -16.4367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4424 -16.8515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7294 -16.4408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7309 -15.6205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0187 -15.2141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3071 -15.6248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3122 -16.4504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0249 -16.8572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0167 -14.3928 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7276 -13.9783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
4 7 2 0
5 8 1 0
1 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
13 17 1 0
17 18 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 246.27 | Molecular Weight (Monoisotopic): 246.1004 | AlogP: 1.27 | #Rotatable Bonds: 4 |
Polar Surface Area: 75.21 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.81 | CX Basic pKa: ┄ | CX LogP: 1.58 | CX LogD: 1.43 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.85 | Np Likeness Score: -0.56 |
References
1. Hondo T, Warizaya M, Niimi T, Namatame I, Yamaguchi T, Nakanishi K, Hamajima T, Harada K, Sakashita H, Matsumoto Y, Orita M, Takeuchi M.. (2013) 4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors., 56 (9): [PMID:23566269] [10.1021/jm400095b] |